Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: a prospective study.
Recently, we demonstrated that cholesterol gallstone-prone C57L/J mice rarely develop gallstones unless they are infected with certain cholelithogenic enterohepatic Helicobacter species. Because the common gastric pathogen H. pylori has been identified in the hepatobiliary tree of cholesterol gallstone patients, we wanted to ascertain if H. pylori is cholelithogenic, by prospectively studying C57L infected mice fed a lithogenic diet. Weanling, Helicobacter spp.-free male C57L mice were either infected with H. pylori SS1 or sham dosed. Mice were then fed a lithogenic diet (1.0% cholesterol, 0.5% cholic acid, and 15% dairy triglycerides) for 8 wk. At 16 wk of age, mice were euthanatized, the biliary phenotype was analyzed microscopically, and tissues were analyzed histopathologically. H. pylori infection did not promote cholesterol monohydrate crystal formation (20% vs. 10%), sandy stone formation (0% for both), or true gallstone formation (20%) compared with uninfected mice fed the lithogenic diet (10%). Additionally, H. pylori failed to stimulate mucin gel accumulation in the gallbladder or alter gallbladder size compared with uninfected animals. H. pylori-infected C57L mice developed moderate to severe gastritis by 12 wk, and the lithogenic diet itself produced lesions in the forestomach, which were exacerbated by the infection. We conclude that H. pylori infection does not play any role in murine cholesterol gallstone formation. Nonetheless, the C57L mouse develops severe lesions of both the glandular and nonglandular stomach in response to H. pylori infection and the lithogenic diet, respectively.
Maurer
Kirk J
KJ
Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Ave., Cambridge, MA 02139, USA. kmaurer@mit.edu
Rogers
Arlin B
AB
Ge
Zhongming
Z
Wiese
Ashley J
AJ
Carey
Martin C
MC
Fox
James G
JG
D000818:Animals; D001646:Bile / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism*; D004269:DNA, Bacterial / Q000032:analysis; D004032:Diet; D005704:Gallbladder / Q000378:metabolism / Q000382:microbiology / Q000473:pathology; D042882:Gallstones / Q000378:metabolism* / Q000382:microbiology*; D016480:Helicobacter pylori / Q000502:physiology*; D008099:Liver / Q000382:microbiology / Q000473:pathology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010641:Phenotype; D016133:Polymerase Chain Reaction; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D013270:Stomach / Q000382:microbiology / Q000473:pathology
D004269:DNA, Bacterial; D002784:Cholesterol